NASDAQ · Analyst Forecast

Tango Therapeutics, Inc. (TNGX) Stock Forecast & Price Target

$22.11 NASDAQ: TNGX Market Cap $3.75B

Price as of Nov 17, 2026 close · Analyst estimates retrieved Nov 12, 2026 · Source: Financial Modeling Prep (analyst estimates) (methodology)

Revenue and earnings estimates published by analysts covering Tango Therapeutics, Inc. (TNGX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Tango Therapeutics, Inc., analysts forecast revenue rising from $62.81M in 2025 to $837.79M in 2030; the average estimate for 2030 earnings per share is $1.13; 10 analysts contribute to these figures. These are forecasts published by analysts, not results.

Analyst price targets

MeasureValue
Current priceWhat the share trades at now.$22.11
Consensus targetThe average of the price targets analysts have published.$47.73
Median targetThe middle target, less affected by a single outlier.$46.00
Highest targetThe most optimistic published target.$69.00
Lowest targetThe most pessimistic published target.$24.00
Difference from priceHow far the consensus target sits from today’s price.+115.9%

A price target is one analyst's forecast of where a share might trade, usually over twelve months. Targets are frequently revised, they disagree with each other, and they are not a measure of what a company is worth.

Revenue forecast (USD)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

YearLowAverageHighAnalysts
2025$62.80M$62.81M$62.82M8
2026$6.06M$6.06M$6.06M9
2027$3.13M$3.13M$3.13M10
2028$44.57M$44.57M$44.57M8
2029$292.92M$292.92M$292.92M5
2030$837.79M$837.79M$837.79M5

Earnings per share forecast

YearLowAverageHighAnalysts
2025−$0.90−$0.87−$0.838
2026−$1.63−$1.49−$1.359
2027−$2.46−$1.79−$1.4510
2028−$2.57−$2.07−$1.498
2029−$1.36−$1.36−$1.365
2030$1.13$1.13$1.135

Tango Therapeutics, Inc. (TNGX) forecast — frequently asked questions

What is the analyst price target for Tango Therapeutics, Inc.?

Analysts covering Tango Therapeutics, Inc. (TNGX) have a consensus price target of $47.73, 115.9% above the current price of $22.11. Published targets range from $24.00 to $69.00. A price target is a forecast, not a measure of value, and targets are revised often.

What are analysts forecasting for Tango Therapeutics, Inc.'s earnings?

The average analyst estimate for Tango Therapeutics, Inc. (TNGX) earnings per share in 2030 is 1.13, with individual estimates between 1.13 and 1.13.

How much revenue is Tango Therapeutics, Inc. expected to make?

Analysts forecast Tango Therapeutics, Inc. (TNGX) revenue of $837.79M in 2030, based on 5 published estimates.

How many analysts cover TNGX?

10 analysts contribute estimates for Tango Therapeutics, Inc. (TNGX). Thin coverage makes an average less reliable.

Analyst forecasts for other Biotechnology stocks

VRTX forecastREGN forecastMRNA forecastRVMD forecastROIV forecastINSM forecastUTHR forecastINCY forecastALNY forecastASND forecastAll Biotechnology stocks

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.